Chicago: Serious tissue damage and disfigurement are a major fallout of most cancer therapies, but the one for breast cancer in particular has life-altering impact on women. Chicago-based Ananda Chakrabarty, a world-renowned pioneering biotech scientist, and Washington-based Susan Finston, a veteran of the biotech industry, together believe they are potentially close to resolving this major medical challenge.Finston passionately talks about the experimental Amrita Breast Cancer Device (ABCD), created by Chakrabarty, and how it has what it takes to deliver locally targeted cancer therapy to the tumour."Our therapeutic approach may provide an important alternative or adjunct to surgery, radiation or chemotherapies that is designed to be non-toxic to healthy cells/tissues in the body," said Finston, who co-founded Ahmedabad (India)-based Amrita Therapeutics, with Chakrabarty, in an interview to Hi India newspaper here.Dividing time between Washington and Ahmedabad, Finston has recently embarked on the independent funding platform Indiegogo where individuals invest modest amounts of money in various projects.
Genetic variants behind dyslexia, language impairment found
Drug to treat osteoporosis prevents growth of breast cancer cells